Premium
Bipolar disorder patients using lithium have lower self‐harm rates
Publication year - 2016
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30169
Subject(s) - quetiapine , olanzapine , bipolar disorder , lithium (medication) , suicide rates , medicine , harm , psychiatry , population , schizophrenia (object oriented programming) , psychology , poison control , injury prevention , emergency medicine , environmental health , social psychology
Bipolar disorder patients taking lithium showed reduced self‐harm and unintentional injury rates compared with patients taking valproate, olanzapine, or quetiapine, a population‐based study conducted in the United Kingdom has found. Researchers could not draw definitive conclusions about the drugs' comparative effects on suicide because of a low overall number of suicides in the study population.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom